# Inositol Pms Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/inositol-pms-randomized-trial-evidence-review
Category: evidence-review
Summary: Inositol Pms Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomize
Last reviewed: 2026-07-09
Reviewed by: Migaku Evidence Review
# Inositol Pms Randomized Trial: What the Evidence Says

## Quick Answer

Inositol Pms Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 randomized trial, 1 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| The Effect of Vitex Agnus - Castus Plant on Some Markers of Oxidative Stress, Lipid Profile and Insulin Resistance in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind Controlled Clinical Trial Study | randomized trial | 2 | 2026-01-01 | 10.5935/1518-0557.20250165 |
| Endocrine roles of vitamin D in female reproduction: Mechanisms and clinical implications | narrative review | 3 | 2026-01-01 | 10.1177/17455057261446942 |

## What The Sources Report

- Defined by the Rotterdam criteria and
endorsed by the 2018 International Evidence-based Guideline, PCOS diagnosis requires
the presence of at least two of the following: hyperandrogenism (biochemical and/or
clinical), chronic anovulation and menstrual dysfunction, and polycystic ovarian
morphology on ultrasonography, after excluding other endocrine disorders (;). [Hatami Aniseh (2026); evidence level 2]
- This
complex disorder poses a significant health burden, increasing the risk of metabolic
and cardiovascular complications, including insulin resistance, obesity,
dyslipidemia, gestational diabetes, type 2 diabetes, and cardiovascular disease. [Hatami Aniseh (2026); evidence level 2]
- While no prior protocol was registered, no quantitative meta-analysis was performed, and a formal risk-of-bias assessment of individual studies was not conducted. [Alsuwaidi Azza (2026); evidence level 3]
- Eligible studies included observational research, randomized controlled trials, and mechanistic investigations examining vitamin D status, supplementation, VDR activity, or associated reproductive outcomes. [Alsuwaidi Azza (2026); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For inositol pms randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Hatami Aniseh (2026). The Effect of Vitex Agnus - Castus Plant on Some
Markers of Oxidative Stress, Lipid Profile and Insulin Resistance in Women with
Polycystic Ovary Syndrome: A Randomized, Double-Blind Controlled Clinical Trial
Study. DOI: 10.5935/1518-0557.20250165. PMCID: PMC13055162. PMID: 41428718. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13055162/
- Alsuwaidi Azza (2026). Endocrine roles of vitamin D in female reproduction: Mechanisms and clinical implications. DOI: 10.1177/17455057261446942. PMCID: PMC13133454. PMID: 42037530. License: https://creativecommons.org/licenses/by-nc/4.0/ https://creativecommons.org/licenses/by-nc/4.0/ https://us.sagepub.co.... https://pmc.ncbi.nlm.nih.gov/articles/PMC13133454/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.